Effects of C825T polymorphism of the GNB3 gene on availability of dopamine transporter in healthy volunteers - A SPECT study

NeuroImage

Volumn 56, Issue 3, 2011, Pages 1526-1530

  Chen, Po See ^a,b   Yeh, Tzung Lieh ^a   Lee, I Hui ^a   Lin, Cheng Bill ^c   Tsai, Hsin Chun ^a,b   Chen, Kao Chin ^a   Chiu, Nan Tsing ^a   Yao, Wei Jen ^a   Yang, Yen Kuang ^a   Chou, Yuan Hwa ^d  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

?3 subunit of G protein; Dopamine transporter; SPECT; TRODAT 1

Indexed keywords

[2 [[2 [[[3 (4 CHLOROPHENYL) 8 METHYL 8 AZABICYCLO[3.2.1]OCT 2 YL]METHYL](2 MERCAPTOETHYL)AMINO]ETHYL]AMINO]ETHANETHIOLATO]OXOTECHNETIUM TC 99M; CYTOSINE; DOPAMINE 2 RECEPTOR; DOPAMINE AUTORECEPTOR; DOPAMINE TRANSPORTER; THYMINE; TROPANE DERIVATIVE;

ADULT; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; FEMALE; GENE; GENETIC VARIABILITY; GENOTYPE; GNB3 GENE; HUMAN; HUMAN EXPERIMENT; ISOTOPE LABELING; MALE; NORMAL HUMAN; OCCIPITAL LOBE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRIATE CORTEX; VOLUNTEER;

ADULT; ALLELES; CORPUS STRIATUM; DNA; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; GENE FREQUENCY; GENOTYPE; HETEROTRIMERIC GTP-BINDING PROTEINS; HUMANS; MALE; ORGANOTECHNETIUM COMPOUNDS; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, DOPAMINE D2; RECEPTORS, G-PROTEIN-COUPLED; SECOND MESSENGER SYSTEMS; SMOKING; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TROPANES;

EID: 79955473167     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2010.10.082     Document Type: Article

References (44)

1. Beal M.F., Martin J.B. Topographical dopamine and serotonin distribution and turnover in rat striatum. Brain Res. 1985, 358:10-15.
2. Bertolino A., Fazio L., Di Giorgio A., Blasi G., Romano R., Taurisano P., Caforio G., Sinibaldi L., Ursini G., Popolizio T., Tirotta E., Papp A., Dallapiccola B., Borrelli E., Sadee W. Genetically determined interaction between the dopamine transporter and the D2 receptor on prefronto-striatal activity and volume in humans. J. Neurosci. 2009, 29:1224-1234.
3. Bonne O., Louzoun Y., Aharon I., Krausz Y., Karger H., Lerer B., Bocher M., Freedman N., Chisin R. Cerebral blood flow in depressed patients: a methodological comparison of statistical parametric mapping and region of interest analyses. Psychiatry Res. 2003, 122:49-57.
4. Brand E., Wang J.G., Herrmann S.M., Staessen J.A. An epidemiological study of blood pressure and metabolic phenotypes in relation to the Gbeta3 C825T polymorphism. J. Hypertens. 2003, 21:729-737.
5. Casiglia E., Tikhonoff V., Caffi S., Martini B., Guidotti F., Bolzon M., Bascelli A., D'Este D., Mazza A., Pessina A.C. Effects of the C825T polymorphism of the GNB3 gene on body adiposity and blood pressure in fertile and menopausal women: a population-based study. J. Hypertens. 2008, 26:238-243.
6. Chang H.H., Chou C.H., Chen P.S., Gean P.W., Huang H.C., Lin C.Y., Yang Y.K., Lu R.B. High prevalence of metabolic disturbances in patients with bipolar disorder in Taiwan. J. Affect. Disord. 2009, 117:124-129.
7. Chang H.H., Gean P.W., Chou C.H., Yang Y.K., Tsai H.C., Lu R.B., Chen P.S. C825T polymorphism of the GNB3 gene on valproate-related metabolic abnormalities in bipolar disorder patients. J. Clin. Psychopharmacol. 2010, 30:512-517.
8. Chang H.H., Yang Y.K., Gean P.W., Huang H.C., Chen P.S., Lu R.B. The role of valproate in metabolic disturbances in bipolar disorder patients. J. Affect. Disord. 2010, 124:319-323.
9. Chen P.S., Yang Y.K., Yeh T.L., Lee I.H., Yao W.J., Chiu N.T., Lu R.B. Correlation between body mass index and striatal dopamine transporter availability in healthy volunteers-a SPECT study. Neuroimage 2008, 40:275-279.
10. Clausius N., Born C., Grunze H. The relevance of dopamine agonists in the treatment of depression. Neuropsychiatry 2009, 23:15-25.
11. Danoviz M.E., Pereira A.C., Mill J.G., Krieger J.E. Hypertension, obesity and GNB 3 gene variants. Clin. Exp. Pharmacol. Physiol. 2006, 33:248-252.
12. Hauner H., Meier M., Jockel K.H., Frey U.H., Siffert W. Prediction of successful weight reduction under sibutramine therapy through genotyping of the G-protein beta3 subunit gene (GNB3) C825T polymorphism. Pharmacogenetics 2003, 13:453-459.
13. Hayakawa T., Takamura T., Abe T., Kaneko S. Association of the C825T polymorphism of the G-protein beta3 subunit gene with hypertension, obesity, hyperlipidemia, insulin resistance, diabetes, diabetic complications, and diabetic therapies among Japanese. Metabolism 2007, 56:44-48.
14. Honey G.D., Suckling J., Zelaya F., Long C., Routledge C., Jackson S., Ng V., Fletcher P.C., Williams S.C., Brown J., Bullmore E.T. Dopaminergic drug effects on physiological connectivity in a human cortico-striato-thalamic system. Brain 2003, 126:1767-1781.
15. Hsieh P.C., Yeh T.L., Lee I.H., Huang H.C., Chen P.S., Yang Y.K., Chiu N.T., Lu R.B., Liao M.H. Correlation between errors on the Wisconsin Card Sorting Test and the availability of striatal dopamine transporters in healthy volunteers. J. Psychiatry Neurosci. 2010, 35:90-94.
16. Hwang W.J., Yao W.J., Wey S.P., Ting G. Reproducibility of 99mTc-TRODAT-1 SPECT measurement of dopamine transporters in Parkinson's disease. J. Nucl. Med. 2004, 45:207-213.
17. Kopf D., Cheng L.S., Blandau P., Hsueh W., Raffel L.J., Buchanan T.A., Xiang A.H., Davis R.C., Rotter J.I., Lehnert H. Association of insulin sensitivity and glucose tolerance with the c.825C>T variant of the G protein beta-3 subunit gene. J. Diabetes Complications 2008, 22:205-209.
18. Lee H.J., Sung S.M., Han C.S., Kim Y.K., Kim S.H., Lee M.S., Joe S.H., Jung I.K., Kim L. G-protein beta3 subunit C825T polymorphism tends to be associated with seasonal variation in young male college students. Neuropsychobiology 2005, 52:135-139.
19. Lin E., Chen P.S. Pharmacogenomics with antidepressants in the STAR*D study. Pharmacogenomics 2008, 9:935-946.
20. Lin E., Chen P.S., Chang H.H., Gean P.W., Tsai H.C., Yang Y.K., Lu R.B. Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 2009, 33:1167-1172.
21. Loring D.W., Meador K.J., Allison J.D., Pillai J.J., Lavin T., Lee G.P., Balan A., Dave V. Now you see it, now you don't: statistical and methodological considerations in fMRI. Epilepsy Behav. 2002, 3:539-547.
22. Mayfield R.D., Zahniser N.R. Dopamine D2 receptor regulation of the dopamine transporter expressed in Xenopus laevis oocytes is voltage-independent. Mol. Pharmacol. 2001, 59:113-121.
23. Meirhaeghe A., Cottel D., Amouyel P., Dallongeville J. Lack of association between certain candidate gene polymorphisms and the metabolic syndrome. Mol. Genet. Metab. 2005, 86:293-299.
24. Michalsen A., Frey U.H., Merse S., Siffert W., Dobos G.J. Hunger and mood during extended fasting are dependent on the GNB3 C825T polymorphism. Ann. Nutr. Metab. 2009, 54:184-188.
25. Mozley P.D., Schneider J.S., Acton P.D., Plossl K., Stern M.B., Siderowf A., Leopold N.A., Li P.Y., Alavi A., Kung H.F. Binding of [99mTc]TRODAT-1 to dopamine transporters in patients with Parkinson's disease and in healthy volunteers. J. Nucl. Med. 2000, 41:584-589.
26. Nestler E.J., Carlezon W.A. The mesolimbic dopamine reward circuit in depression. Biol. Psychiatry 2006, 59:1151-1159.
27. Neves S.R., Ram P.T., Iyengar R. G protein pathways. Science 2002, 296:1636-1639.
28. Newberg A., Lerman C., Wintering N., Ploessl K., Mozley P.D. Dopamine transporter binding in smokers and nonsmokers. Clin. Nucl. Med. 2007, 32:452-455.
29. Peters B.J., Maitland-van der Zee A.H., Stricker B.H., van Wieren-de Wijer D.B., de Boer A., Kroon A.A., de Leeuw P.W., Schiffers P., Janssen R.G., van Duijn C.M., Klungel O.H. Effectiveness of statins in the reduction of the risk of myocardial infarction is modified by the GNB3 C825T variant. Pharmacogenet. Genomics 2008, 18:631-636.
30. Reagan L.P. Insulin signaling effects on memory and mood. Curr. Opin. Pharmacol. 2007, 7:633-637.
31. Ruhe H.G., Mason N.S., Schene A.H. Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies. Mol. Psychiatry 2007, 12:331-359.
32. Serretti A., Lorenzi C., Cusin C., Zanardi R., Lattuada E., Rossini D., Lilli R., Pirovano A., Catalano M., Smeraldi E. SSRIs antidepressant activity is influenced by G beta 3 variants. Eur. Neuropsychopharmacol. 2003, 13:117-122.
33. Sershen H., Hashim A., Lajtha A. Serotonin-mediated striatal dopamine release involves the dopamine uptake site and the serotonin receptor. Brain Res. Bull. 2000, 53:353-357.
34. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., Hergueta T., Baker R., Dunbar G.C. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 1998, 59(Suppl 20):22-33. quiz 34-57.
35. Siffert W., Rosskopf D., Siffert G., Busch S., Moritz A., Erbel R., Sharma A.M., Ritz E., Wichmann H.E., Jakobs K.H., Horsthemke B. Association of a human G-protein ?3 subunit variant with hypertension. Nat. Genet. 1998, 18:45-48.
36. Siffert W., Forster P., Jockel K.H., Mvere D.A., Brinkmann B., Naber C., Crookes R., Du P.H.A., Epplen J.T., Fridey J., Freedman B.I., Muller N., Stolke D., Sharma A.M., Al Moutaery K., Grosse-Wilde H., Buerbaum B., Ehrlich T., Ahmad H.R., Horsthemke B., Du Toit E.D., Tiilikainen A., Ge J., Wang Y., Rosskopf D., et al. Worldwide ethnic distribution of the G protein beta3 subunit 825T allele and its association with obesity in Caucasian, Chinese, and Black African individuals. J. Am. Soc. Nephrol. 1999, 10:1921-1930.
37. Souza R.P., De Luca V., Muscettola G., Rosa D.V., de Bartolomeis A., Romano Silva M., Kennedy J.L. Association of antipsychotic induced weight gain and body mass index with GNB3 gene: a meta-analysis. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32:1848-1853.
38. Wang G.J., Volkow N.D., Logan J., Pappas N.R., Wong C.T., Zhu W., Netusil N., Fowler J.S. Brain dopamine and obesity. Lancet 2001, 357:354-357.
39. Wang Y.C., Bai Y.M., Chen J.Y., Lin C.C., Lai I.C., Liou Y.J. C825T polymorphism in the human G protein beta3 subunit gene is associated with long-term clozapine treatment-induced body weight change in the Chinese population. Pharmacogenet. Genomics 2005, 15:743-748.
40. Willeit M., Praschak-Rieder N., Zill P., Neumeister A., Ackenheil M., Kasper S., Bondy B. C825T polymorphism in the G protein beta3-subunit gene is associated with seasonal affective disorder. Biol. Psychiatry 2003, 54:682-686.
41. Yang Y.K., Chiu N.T., Chen C.C., Chen M., Yeh T.L., Lee I.H. Correlation between fine motor activity and striatal dopamine D2 receptor density in patients with schizophrenia and healthy controls. Psychiatry Res. 2003, 123:191-197.
42. Yang Y.K., Yao W.J., Yeh T.L., Lee I.H., Chen P.S., Lu R.B., Chiu N.T. Decreased dopamine transporter availability in male smokers - a dual isotope SPECT study. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32:274-279.
43. Yang Y.K., Yeh T.L., Yao W.J., Lee I.H., Chen P.S., Chiu N.T., Lu R.B. Greater availability of dopamine transporters in patients with major depression - a dual-isotope SPECT study. Psychiatry Res. 2008, 162:230-235.
44. Yeh T.L., Lee I.H., Chen P.S., Yu L., Cheng S.H., Yao W.J., Yang Y.K., Lu R.B., Chiu N.T. Social support and striatal dopaminergic activities: is there a connection?. Prog. Neuropsychopharmacol. Biol. Psychiatry 2009, 33:1141-1146.